BDC to acquire Achilles

Achilles, a global leader and partner of choice for supply chain risk and performance management, today announces an agreement to be acquired by Bridgepoint, the international private assets fund management group.

The acquisition marks a new chapter for Achilles. Despite the recent global turmoil and uncertainty, Achilles has continued to partner with customers, build new value, bring new products to market and add new customers to the portfolio.

Over the past decade supply chain risk management has increased in complexity due to numerous environmental, social, and economic drivers. Issues such as sustainability, modern slavery and equality, diversity and inclusion, as well the increased risk of sophisticated cyber-attacks have changed the way in which supply chains need to be managed: Achilles’ solutions enable customers to mitigate risk and make informed business decisions for their supply chains.

Partnering with Bridgepoint will give Achilles access to the capital and expertise to significantly expand the solution set, both organically and through M&A, delivering new capabilities around key focus areas like ESG, CSR, EDI, Health and Safety, and supply chain mapping, all of which are critical customer needs.

Matt Legg, Director of Bridgepoint Development Capital, said: “Supply chains across the world are under increased pressure and scrutiny, creating opportunities for those companies who are able to provide data-driven solutions to ensure more sustainable and ethical solutions. Achilles, with its global platform, breadth of risk coverage, in-house audit capabilities, and depth of data validation provides a compelling proposition to its customers. We look forward to working with the Achilles management team and have already identified multiple avenues to drive value creation in a sector which is growing due to increasing supply chain complexity and corporate focus on supply chain risk and ESG.”

Jay Katzen, CEO of Achilles, commented: “I am delighted Bridgepoint will be working with the team at Achilles for the next chapter in our story. Our teams have built a great rapport, and we have a shared vision about both the opportunity and goal to expand our solutions, helping our customers drive a more sustainable future.

I believe this is a pivotal moment, not just for my colleagues and I at Achilles, but for our customers and partners as well. With this in mind, I’d like to thank Hg and Achilles’ Chairman Craig Rodgerson, for their support in driving success for Achilles.

With over 30 years’ experience, sector leading technology and extremely engaged employees, Achilles is uniquely well placed to take advantage of the opportunities that evolve as the world looks to make supply chains more sustainable, efficient and ethical. Achilles creates opportunity and provides the sector leading insight that enables better, value added decision making for our customers, from the smallest micro business to FTSE 100 companies. It is this strength of purpose and range of strategic opportunity that the team at Bridgepoint recognise and value - I’m excited about all that the future holds for Achilles and our customers.”

The investment in Achilles was made by the Bridgepoint Development Capital fund IV. Bridgepoint was advised on the transaction by: Raymond James (M&A), Ropes & Gray (Legal), GCA Altium (Debt), McKinsey (Commercial), BDO (Financial & Tax) and Intechnica (Technology). Hg and Achilles were advised by Baird (M&A) and Barclays (M&A).

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.